2024 annual financial data
China SXT Pharmaceuticals 2024 Net margin
China SXT Pharmaceuticals 2024 net margin with verified reported values.
Direct answer
Net margin was -160.67%.
Operating income was -2,515,217 USD and net income was -3,098,532 USD.
Operating cash flow was -1,928,053 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,928,497 USD
- Operating income
- -2,515,217 USD
- Net income
- -3,098,532 USD
- Operating cash flow
- -1,928,053 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all China SXT Pharmaceuticals financial years